245 related articles for article (PubMed ID: 27123851)
21. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.
Zak Z; Gelebart P; Lai R
Leukemia; 2010 Aug; 24(8):1476-86. PubMed ID: 20520642
[TBL] [Abstract][Full Text] [Related]
22. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
23. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
24. Enteroendocrine cells express functional Toll-like receptors.
Bogunovic M; Davé SH; Tilstra JS; Chang DT; Harpaz N; Xiong H; Mayer LF; Plevy SE
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1770-83. PubMed ID: 17395901
[TBL] [Abstract][Full Text] [Related]
25. PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment.
Singh AR; Peirce SK; Joshi S; Durden DL
Exp Cell Res; 2014 Sep; 327(1):78-90. PubMed ID: 24881819
[TBL] [Abstract][Full Text] [Related]
26. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
27. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells.
Sun J; Fegan PE; Desai AS; Madara JL; Hobert ME
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G767-78. PubMed ID: 17138965
[TBL] [Abstract][Full Text] [Related]
28. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas.
Wasik AM; Christensson B; Sander B
Semin Cancer Biol; 2011 Nov; 21(5):313-21. PubMed ID: 22024769
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.
Mohanty S; Mohanty A; Sandoval N; Tran T; Bedell V; Wu J; Scuto A; Murata-Collins J; Weisenburger DD; Ngo VN
Leuk Lymphoma; 2017 Mar; 58(3):676-688. PubMed ID: 27338091
[TBL] [Abstract][Full Text] [Related]
31. Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3β-dependent mechanism.
Samara A; Shapira S; Lubin I; Shpilberg O; Avigad S; Granot G; Raanani P
Br J Haematol; 2021 Feb; 192(4):747-760. PubMed ID: 33521925
[TBL] [Abstract][Full Text] [Related]
32. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
33. CD40 ligand stimulation inhibits the proliferation of mantle cell lymphoma lines.
Jin Z; Teramoto N; Hayashi K; Liu YX; Jin G; Oka T; Takahashi K; Yoshino T; Akagi T
Anticancer Res; 2004; 24(2B):691-7. PubMed ID: 15161013
[TBL] [Abstract][Full Text] [Related]
34. Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study.
Chung R; Peters AC; Armanious H; Anand M; Gelebart P; Lai R
Int J Clin Exp Pathol; 2010 Jan; 3(3):244-53. PubMed ID: 20224723
[TBL] [Abstract][Full Text] [Related]
35. Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma.
Dal Col J; Zancai P; Terrin L; Guidoboni M; Ponzoni M; Pavan A; Spina M; Bergamin S; Rizzo S; Tirelli U; De Rossi A; Doglioni C; Dolcetti R
Blood; 2008 May; 111(10):5142-51. PubMed ID: 18339899
[TBL] [Abstract][Full Text] [Related]
36. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
[TBL] [Abstract][Full Text] [Related]
37. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Beltran E; Fresquet V; Martinez-Useros J; Richter-Larrea JA; Sagardoy A; Sesma I; Almada LL; Montes-Moreno S; Siebert R; Gesk S; Calasanz MJ; Malumbres R; Rieger M; Prosper F; Lossos IS; Piris MA; Fernandez-Zapico ME; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12461-6. PubMed ID: 21746927
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
39. Altered apoptosis pathways in mantle cell lymphoma.
Rummel MJ; de Vos S; Hoelzer D; Koeffler HP; Hofmann WK
Leuk Lymphoma; 2004 Jan; 45(1):49-54. PubMed ID: 15061196
[TBL] [Abstract][Full Text] [Related]
40. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
